Related Experiment Video
Updated: May 28, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Role of Gram-Negative Bacterial Infections in Acute-On-Chronic Liver Failure
Camilla Cadoli1, Volker Müller2, Christoph Welsch3
1Institute for Medical Microbiology and Infection Control, University Hospital, Goethe University, Frankfurt am Main, Germany.
Summary
Acute-on-chronic liver failure (ACLF) involves gut bacteria translocating to the liver, causing inflammation and organ failure. This review explores how bacteria, their metabolites, and antimicrobial resistance drive ACLF progression and outcomes.
Area of Science:
- Hepatology
- Microbiology
- Immunology
Background:
- Acute-on-chronic liver failure (ACLF) is a severe systemic condition characterized by acute decompensation of cirrhosis, leading to multi-organ failure.
- Systemic inflammation, often triggered by gut-derived factors, plays a critical role in ACLF pathogenesis.
- Bacterial translocation from the gut is a key initiator of the inflammatory cascade in ACLF.
Purpose of the Study:
- To review the multifaceted roles of bacteria, their metabolites, and antimicrobial resistance in the development and progression of ACLF.
- To elucidate the mechanisms by which gut dysbiosis and bacterial products contribute to systemic inflammation and organ dysfunction in ACLF.
- To understand the impact of bacterial infections and antimicrobial resistance on ACLF outcomes, irrespective of specific diagnostic criteria.
Main Methods:
- Literature review synthesizing current research on bacterial involvement in ACLF.
- Analysis of studies investigating bacterial translocation, gut barrier integrity, and microbial metabolites in liver cirrhosis.
- Examination of data on the prevalence and impact of bacterial infections and antimicrobial resistance in ACLF patients.
Main Results:
- Bacterial translocation, particularly of Gram-negative bacteria, is a significant driver of ACLF.
- Bacterial metabolites and the resulting systemic inflammation exacerbate liver damage and contribute to multi-organ failure.
- Antimicrobial resistance in gut bacteria complicates infection management and worsens ACLF prognosis.
- Infections like peritonitis, pneumonia, and UTIs are common triggers for ACLF onset.
Conclusions:
- Bacteria, their metabolites, and antimicrobial resistance are central to ACLF pathogenesis and poor outcomes.
- Targeting gut barrier integrity and microbial dysbiosis presents potential therapeutic strategies for ACLF.
- Further research is needed to fully understand the complex interplay between the gut microbiome and ACLF.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...